ClinicalTrials.gg
RecruitingNCT06520137Updated Jul 25, 2024

Third Molars Extraction and Periodontal Disease

An observational study in Periodontal Diseases, sponsored by Azienda Ospedaliera Universitaria Senese. Recruiting at 1 site in Italy. Open to participants aged 19 Years to 64 Years. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by Azienda Ospedaliera Universitaria Senese · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
126
Ages
19 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 72 studies in Periodontal Diseases with a site in Italy — 18 open to participants now, 20 under way, none of them phase 3. Periodontal Diseases · Italy.

Planned enrollment
12th of 24
126 · median 126
Started
2024
with 5 others
Observational
24 of 72
7 open now
Primary completion
2026-03
later than 8 of 19 live
Registered
55th of 72
by date

Among the 72 studies in Periodontal Diseases with a site in Italy, this one is the 12th largest by planned enrollment of the 24 observational ones that give a count, is one of 6 that started in 2024, is one of 24 observational ones, reaches primary completion later than 8 of the 19 other live ones, and was the 55th registered.

Periodontal Diseases

871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.

Browse Periodontal Diseases studies →

Open to participants now

18 of the 72 studies in Periodontal Diseases with a site in Italy are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.

This study: 19 Years to 64 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Periodontal Diseases with a site in Italy, or all of them as a file.
02

Study summary

The aim of the study is to evaluate the changes in periodontal conditions on the distal aspect of the second maxillary molar after the extraction of the maxillary wisdom tooth. As secondary outcome patient- related and tooth-related factors will be analysed to evaluate their effects on the periodontal varibales during time.

03

Conditions studied

  • Periodontal Diseases

Browse trials for

04

Who can participate

Ages eligible
19 Years to 64 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Hospital population.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age more than 18 years or older
  • Presence of an impacted upper wisdom tooth that need to undergo surgical extraction
  • Participants need to be able to sign and understand the and to follow the study-related procedures.

Exclusion criteria

Exclusion Criteria:

  • People that have compromised general health conditions (ASA 3, 4, 5, 6)
  • Patients that assumed antibiotics in the last 6 months
  • Pregnant or breastfeeding women
  • Patients who suffer from periodontitis stage III and IV
  • Presence of a third molar with incomplete root formation is not taken into account for the surgical extraction.
  • Smoker patients
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
126 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group A with PPD ≤ 3 mm

    Procedure: Tooth extraction

  • Group B with PPD ≥ 4 mm

    Procedure: Tooth extraction

Interventions

  • ProcedureTooth extraction

    Extraction of maxillary third molars

06

What researchers measure

Primary outcomes

  1. Probing Pockeet Depth (PPD)

    Distance between the free gingival margin and the apical location of the probe's tip.

    Time frame: Baseline, 1 month, 6 months, 12 months, 24 months

  2. Bone Level (BL)

    Distance between the bone crest and the cemento-enamel junction (CEJ)

    Time frame: Baseline, 1 month, 6 months, 12 months, 24 months

Secondary outcomes

  1. Type of impaction

    According to Archer's classification it is possible to have seven types of impaction: mesio-angular, disto-angular, bucco-angular, linguo-angular, horizontal, vertical, inverted.

    Time frame: Baseline

  2. Clinical Attachment Level (CAL)

    Distance between the cemento-enamel junction and the apical location of the probe's tip

    Time frame: Baseline, 1 month, 6 months, 12 months, 24 months

  3. Recession (REC)

    Distance between the free gingival margine and the cemento-enamel junction (CEJ)

    Time frame: Baseline, 1 month, 6 months, 12 months, 24 months

  4. Keratinized Tissue (KT)

    Distance between the muco-gingival line and the free gingival margin

    Time frame: Baseline, 1 month, 6 months, 12 months, 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Mar 2026, 24 months after the start.

Of 79 non-industry observational studies under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 24 months is above that.

Counting every sponsor, half of 83 studies reached it within 13 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2024
First posted
Jul 25, 2024
StartActual
Mar 27, 2024
Primary completionEst.
Mar 27, 2026
CompletionEst.
Sep 15, 2026
Last update
Jul 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06520137
Lead sponsor
Azienda Ospedaliera Universitaria Senese
Responsible party
Malpassi Chiara (Doctor, Azienda Ospedaliera Universitaria Senese) — Principal investigator
First posted
Jul 25, 2024
Start date
Mar 27, 2024
Primary completion
Mar 27, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Jul 25, 2024

Study contacts

Chiara Malpassi
Contact
chiara.malpassi@gmail.com
+ 39 3331375702
Simone Grandini
Contact
grandini@unisi.it
+39 3357045335

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion